Amgen leads market declines while investors monitor oil-driven inflation and rising bond yields ahead of critical Federal Reserve policy decisions.
Amgen shares dropped 5% pre-market following disappointing clinical trial results from Novartis regarding a competing cardiovascular treatment. This negative sentiment is expected to contribute to a decline in the Dow Jones 30 index.
It fell 5% due to concerns over competing cardiovascular treatment data from Novartis.
Ethereum is currently exhibiting a classic Wyckoff distribution pattern, which technical analysts suggest could precede a 10% price decline. This technical setup serves as a warning for traders expecting a potential short-term pullback.
The technical setup warns of a potential 10% dip based on Wyckoff analysis.
BNB is being monitored for a critical breakout level at $740, which analysts believe could trigger a significant move toward $825. This forecast relies on the asset clearing established resistance levels.
If it breaks above $740, the path could open toward $825.
Light Sweet Crude (WTI) is a primary driver of current market volatility, as oil-related inflation expectations weigh heavily on broader equity indices. The article highlights that energy exposure remains a critical factor in the fundamental backdrop for major indices like the Dow Jones 30.
It serves as a primary indicator for inflation expectations which influence Federal Reserve rate hike probabilities.
Amgen shares tumbled 5% pre-market following Novartis trial data, dragging on the Dow Jones. Meanwhile, broader equity markets remain cautious as oil inflation concerns and a 4.78% 10-year Treasury yield test investor sentiment ahead of key CPI and PPI data releases.
Amgen shares are down 5% pre-market after Novartis reported clinical trial data that raised concerns regarding Amgen's competing cardiovascular treatment exposure.
Market volatility is primarily driven by persistent oil inflation expectations, rising Treasury yields, and uncertainty surrounding upcoming Federal Reserve rate decisions.